國立虎尾科技大學 |

Regulatory Aspects of Gene Therapy and Cell Therapy Products = A Global Perspective /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Regulatory Aspects of Gene Therapy and Cell Therapy Products/ edited by Maria Cristina Galli, Mercedes Serabian.
Reminder of title:	A Global Perspective /
other author:	Galli, Maria Cristina.
Description:	XII, 230 p. 23 illus., 17 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Gene therapy. -
Online resource:	https://doi.org/10.1007/978-3-319-18618-4
ISBN:	9783319186184

Regulatory Aspects of Gene Therapy and Cell Therapy Products = A Global Perspective /
Regulatory Aspects of Gene Therapy and Cell Therapy ProductsA Global Perspective /[electronic resource] :edited by Maria Cristina Galli, Mercedes Serabian. - 1st ed. 2015. - XII, 230 p. 23 illus., 17 illus. in color.online resource. - American Society of Gene & Cell Therapy,8712626-7713 ;. - American Society of Gene & Cell Therapy,848.

1. Regulatory Oversight of Gene Therapy and Cell Therapy Products in the US - FDA/CBER -- 2. US Oversight of Gene Therapy Products – NIH RAC -- 3. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Canada - Health Canada -- 4. Overview of the Regulatory Oversight Implemented by the French Regulatory Authorities for the Clinical Investigation of Gene Therapy and Cell Therapy Products -- 5. Regulation of Clinical Trials with Advanced Therapy Medicinal Products (ATMP) in Germany -- 6. EU Clinical Trials Regulatory Oversight of Advanced Therapy Medicinal Products (ATMP): Perspectives from Various Member States -- 7. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Switzerland - Swissmedic -- 8. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Japan - Japan Ministry of Health, Labour and Welfare (MHLW) and Pharmaceutical and Medical Device Agency (PMDA) -- 9. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Korea - Korean Ministry of Food and Drug Safety (MFDS) -- 10. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Taiwan - Taiwan Food and Drug Administration (TFDA) -- 11. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Singapore - Singapore Health Science Authorities (HSA) -- 12. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Brazil - National Health Surveillance Agency (ANVISA).

Medical literature for health care practitioners on the evaluation and treatment of breastfeeding issues has been disjointed, conflicting, and difficult to find. The field of breastfeeding medicine itself is nonexistent—there are no "breastfeeding doctors" who are specifically trained to understand this complex and interactive process. While much of the literature about breastfeeding describes how it "should" work, there is currently nothing available to explain why it often fails and how to treat it. Clinician’s Guide to Breastfeeding: Evidence-based Evaluation and Management is written for health care practitioners who work with breastfeeding mothers; physicians, nurses, nurse practitioners, and lactation consultants. It provides clear information and clinically tested strategies to help professionals guide new mothers to breastfeed successfully. The first of its kind to consider the entirety of the breastfeeding experience, Clinician’s Guide to Breastfeeding is written by Dr. Linda D. Dahl, a leading expert on the subject. It is a comprehensive review of breastfeeding, covering objective analyses of ideal or “normal” nursing, as well as the evaluation and treatment of abnormal nursing, including case studies to illustrate the treatment decision-making process.

ISBN: 9783319186184

Standard No.: 10.1007/978-3-319-18618-4doiSubjects--Topical Terms:

582271
Gene therapy.

LC Class. No.: RB155.8

Dewey Class. No.: 615.895

Regulatory Aspects of Gene Therapy and Cell Therapy Products = A Global Perspective /
LDR:04218nam a22004095i 4500 001 961004
003 DE-He213
005 20200630065113.0
007 cr nn 008mamaa
008 201211s2015 gw | s |||| 0|eng d
020 $a 9783319186184 $9 978-3-319-18618-4
024 7 $a 10.1007/978-3-319-18618-4 $2 doi
035 $a 978-3-319-18618-4
050 4 $a RB155.8
072 7 $a MJZ $2 bicssc
072 7 $a MED107000 $2 bisacsh
072 7 $a MKZV $2 thema
082 0 4 $a 615.895 $2 23
245 1 0 $a Regulatory Aspects of Gene Therapy and Cell Therapy Products $h [electronic resource] : $b A Global Perspective / $c edited by Maria Cristina Galli, Mercedes Serabian.
250 $a 1st ed. 2015.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a XII, 230 p. 23 illus., 17 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a American Society of Gene & Cell Therapy, $x 2626-7713 ; $v 871
505 0 $a 1. Regulatory Oversight of Gene Therapy and Cell Therapy Products in the US - FDA/CBER -- 2. US Oversight of Gene Therapy Products – NIH RAC -- 3. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Canada - Health Canada -- 4. Overview of the Regulatory Oversight Implemented by the French Regulatory Authorities for the Clinical Investigation of Gene Therapy and Cell Therapy Products -- 5. Regulation of Clinical Trials with Advanced Therapy Medicinal Products (ATMP) in Germany -- 6. EU Clinical Trials Regulatory Oversight of Advanced Therapy Medicinal Products (ATMP): Perspectives from Various Member States -- 7. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Switzerland - Swissmedic -- 8. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Japan - Japan Ministry of Health, Labour and Welfare (MHLW) and Pharmaceutical and Medical Device Agency (PMDA) -- 9. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Korea - Korean Ministry of Food and Drug Safety (MFDS) -- 10. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Taiwan - Taiwan Food and Drug Administration (TFDA) -- 11. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Singapore - Singapore Health Science Authorities (HSA) -- 12. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Brazil - National Health Surveillance Agency (ANVISA).
520 $a Medical literature for health care practitioners on the evaluation and treatment of breastfeeding issues has been disjointed, conflicting, and difficult to find. The field of breastfeeding medicine itself is nonexistent—there are no "breastfeeding doctors" who are specifically trained to understand this complex and interactive process. While much of the literature about breastfeeding describes how it "should" work, there is currently nothing available to explain why it often fails and how to treat it. Clinician’s Guide to Breastfeeding: Evidence-based Evaluation and Management is written for health care practitioners who work with breastfeeding mothers; physicians, nurses, nurse practitioners, and lactation consultants. It provides clear information and clinically tested strategies to help professionals guide new mothers to breastfeed successfully. The first of its kind to consider the entirety of the breastfeeding experience, Clinician’s Guide to Breastfeeding is written by Dr. Linda D. Dahl, a leading expert on the subject. It is a comprehensive review of breastfeeding, covering objective analyses of ideal or “normal” nursing, as well as the evaluation and treatment of abnormal nursing, including case studies to illustrate the treatment decision-making process.
650 0 $a Gene therapy. $3 582271
650 1 4 $a Gene Therapy. $3 580629
700 1 $a Galli, Maria Cristina. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1068835
700 1 $a Serabian, Mercedes. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1068836
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319186177
776 0 8 $i Printed edition: $z 9783319186191
776 0 8 $i Printed edition: $z 9783319357294
830 0 $a American Society of Gene & Cell Therapy, $x 2626-7713 ; $v 848 $3 1254617
856 4 0 $u https://doi.org/10.1007/978-3-319-18618-4
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)